Completed NA INTERVENTIONAL 2-arm NCT04536129

Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure

Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure in Patients With and Without Glaucoma

Sponsor: Medivis SRL

Conditions Glaucoma Ocular Surface Disease

Interventions Hydrocortisone (CORTIVIS ®)

Updated 6 times since 2020 Last updated: Sep 30, 2021 Started: Nov 4, 2019 Primary completion: Mar 4, 2020 Completion: Mar 4, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Glaucoma and Ocular Surface Disease and is currently completed. Medivis SRL leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Completed NA
Sep 2024 — Feb 2026 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Oct 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medivis SRL
University of Molise

Data source: University of Molise

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Campobasso, Italy